Journal of Medical Primatology · 1994 · 17 citations · 17 references
ImmunodeficienciesImmunologyImmunodominanceImmunotherapyCynomolgus MonkeysHuman RetrovirusVaccine DevelopmentVirologyChronic Viral InfectionHivAids PathogenesisVarious AdjuvantsVaccinationWhole Inactivated VaccineMid 50Antiviral ResponseVaccine DesignMedicineVaccine ResearchViral Immunity
Twenty‐one cynomolgus monkeys were immunized with whole inactivated HIV‐2 preparations administered with various adjuvants (incomplete Freund's adjuvant, Alum, Ribi, MDP, or Iscoms) and challenged with 10 or 100 MID 50 of a homologous monkey‐cell grown, cell‐free HIV‐2. Seven animals were completely protected against infection, three showed reduced virus replication. The vaccines elicited neutralizing and ADCC antibodies; the titers did not correlate with protection. Immunization with a whole inactivated vaccine can protect primates from intravenous challenge with a monkey‐cell grown cell‐free human immunodeficiency virus type 2.
17
A Formalin-Inactivated Whole SIV Vaccine Confers Protection in Macaques
Michael Murphey‐Corb, Louis N. Martin, B. Davison‐Fairburn et al. · Science · 1989 · 406 citations
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
Marc Girard, M. P. Kieny, Abraham Pinter et al. · Proceedings of the National Academy of Sciences · 1991 · 353 citations · Full text
Primary Immunodeficiency, Vaccination, Chimpanzees Confers Protection +14